Synchrogenix is a global scientific and regulatory consultancy with over 170 employees. We provide a comprehensive solution aimed at helping our sponsors navigate the global regulatory maze to increase access to treatments and maximize business outcomes. Our services include program leadership and management, regulatory and medical writing, and transparency and disclosure compliance services from early phase development through post-approval. Our medical writers and subject matter experts fit seamlessly and naturally into client teams. They come from various roles in the pharmaceutical industry, spanning all functional areas and a wide breadth of therapeutic area experience. With their complementary backgrounds, Synchrogenix is able to provide expertise across all functional areas: nonclinical; clinical; chemistry, manufacturing and controls (CMC); and drug safety.
Synchrogenix serves dinner to the Ronald McDonald House of Delaware